BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang W, Frankel WN. Overlaps, gaps, and complexities of mouse models of Developmental and Epileptic Encephalopathy. Neurobiol Dis 2021;148:105220. [PMID: 33301879 DOI: 10.1016/j.nbd.2020.105220] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Cunningham MO. Rebuttal from Mark O. Cunningham. J Physiol 2022. [PMID: 36149740 DOI: 10.1113/JP283576] [Reference Citation Analysis]
2 Schirmer C, Abboud MA, Lee SC, Bass JS, Mazumder AG, Kamen JL, Krishnan V. Home-cage behavior in the Stargazer mutant mouse. Sci Rep 2022;12:12801. [PMID: 35896608 DOI: 10.1038/s41598-022-17015-3] [Reference Citation Analysis]
3 Wang M, Cotter E, Wang YJ, Fu X, Whittsette AL, Lynch JW, Wiseman RL, Kelly JW, Keramidas A, Mu TW. Pharmacological activation of ATF6 remodels the proteostasis network to rescue pathogenic GABAA receptors. Cell Biosci 2022;12:48. [PMID: 35477478 DOI: 10.1186/s13578-022-00783-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Robens BK, Yang X, McGraw CM, Turner LH, Robens C, Thyme S, Rotenberg A, Poduri A. Mosaic and non-mosaic protocadherin 19 mutation leads to neuronal hyperexcitability in zebrafish. Neurobiol Dis 2022;:105738. [PMID: 35460869 DOI: 10.1016/j.nbd.2022.105738] [Reference Citation Analysis]
5 Schirmer C, Abboud MA, Lee SC, Bass JS, Mazumder AG, Kamen JL, Krishnan V. On the Mental Status of Stargazer Mice.. [DOI: 10.1101/2022.02.21.481350] [Reference Citation Analysis]
6 Wong JC, Butler KM, Shapiro L, Thelin JT, Mattison KA, Garber KB, Goldenberg PC, Kubendran S, Schaefer GB, Escayg A. Pathogenic in-Frame Variants in SCN8A: Expanding the Genetic Landscape of SCN8A-Associated Disease. Front Pharmacol 2021;12:748415. [PMID: 34867351 DOI: 10.3389/fphar.2021.748415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Brock DC, Demarest S, Benke TA. Clinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies. Neurotherapeutics 2021;18:1445-57. [PMID: 34595733 DOI: 10.1007/s13311-021-01123-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Robens BK, Yang X, Mcgraw CM, Turner LH, Robens C, Thyme S, Rotenberg A, Poduri A. Mosaic and non-mosaic protocadherin 19 mutation leads to neuronal hyperexcitability in zebrafish.. [DOI: 10.1101/2021.09.03.458732] [Reference Citation Analysis]
9 Merseburg A, Kasemir J, Buss EW, Leroy F, Bock T, Porro A, Barnett A, Tröder SE, Engeland B, Stockebrand M, Moroni A, Siegelbaum SA, Isbrandt D, Santoro B. Seizures, behavioral deficits and adverse drug responses in two new genetic mouse models of HCN1 epileptic encephalopathy.. [DOI: 10.1101/2021.08.16.456452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]